Market Place
Sourcing Support
Tenaya Shares Interim RIDGE Data on PKP2-ARVC at Heart Rhythm 2025
24 Apr 2025 //
GLOBENEWSWIRE
Tenaya To Join March Investor Conferences
03 Mar 2025 //
GLOBENEWSWIRE
Tenaya Therapeutics Reports Q3 2024 Financials & Business Update
06 Nov 2024 //
GLOBENEWSWIRE
Tenaya Therapeutics Reports Q2 2024 Results And Business Update
08 Aug 2024 //
GLOBENEWSWIRE
Tenaya Therapeutics Announces Research Leadership Updates
27 Jun 2024 //
GLOBENEWSWIRE
Tenaya to Participate at the TD Cowen Genetic Medicines & RNA Summit
18 Jun 2024 //
GLOBENEWSWIRE
Bolt Bio halves workforce, while Tenaya lays off 5th of staff
15 May 2024 //
FIERCE BIOTECH
Tenaya Therapeutics Reports Q1 2024 Results, Business Update
14 May 2024 //
GLOBENEWSWIRE
Tenaya Therapeutics Reports4Q FYR 2023 & Provides Business Update
18 Mar 2024 //
GLOBENEWSWIRE
Tenaya Reports Fourth Quarter and Full Year 2023 Financial Results
18 Mar 2024 //
GLOBENEWSWIRE
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences
27 Feb 2024 //
GLOBENEWSWIRE
Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data
26 Feb 2024 //
GLOBENEWSWIRE
Tenaya Therapeutics Announces Pricing of Underwritten Offering
08 Feb 2024 //
PRESS RELEASE
Tenaya to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 //
GLOBENEWSWIRE
Tenaya to Participate at the 35th Annual Piper Sandler Healthcare Conference
21 Nov 2023 //
GLOBENEWSWIRE
Tenaya Therapeutics Reports Third Quarter 2023 Financial Results
08 Nov 2023 //
GLOBENEWSWIRE
Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401
26 Oct 2023 //
GLOBENEWSWIRE
Tenaya Therapeutics Presents Data from HDAC6 Inhibitor Program TN-301
09 Oct 2023 //
GLOBENEWSWIRE
Tenaya Publishes Data Highlighting the Potential of Cellular Reprogramming
02 Oct 2023 //
GLOBENEWSWIRE
Tenaya to Present Data for TN-301 and TN-201 at Upcoming Medical Conferences
21 Sep 2023 //
GLOBENEWSWIRE
Tenaya Therapeutics to Participate at the 21st Annual Morgan Stanley Conference
31 Aug 2023 //
GLOBENEWSWIRE
Tenaya Therapeutics Reports Second Quarter 2023 Financial Results
09 Aug 2023 //
GLOBENEWSWIRE
Tenaya to Participate at the 43rd Annual Canaccord Genuity Growth Conference
02 Aug 2023 //
GLOBENEWSWIRE
Tenaya Therapeutics Reports 1Q 2023FYR &Provides Business Update
10 May 2023 //
GLOBENEWSWIRE
Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering
03 May 2023 //
GLOBENEWSWIRE
Tenaya Therapeutics Receives FDA Fast Track Designation for TN-201
02 May 2023 //
GLOBENEWSWIRE
Tenaya to Participate at Chardan`s 7th Annual Genetic Medicines Summit
22 Apr 2023 //
PRESS RELEASE
Tenaya Therapeutics to Participate at Chardan`s 7th Annual Genetic Medicines
21 Apr 2023 //
GLOBENEWSWIRE
Tenaya Therapeutics to Participate in Upcoming Investor Conferences
07 Feb 2023 //
GLOBENEWSWIRE
Tenaya Therapeutics Announces TN-201 IND Clearance & Anticipated 2023 Milestones
09 Jan 2023 //
GLOBENEWSWIRE
Tenaya Therapeutics Appoints Amy Burroughs to Board of Directors
07 Dec 2022 //
GLOBENEWSWIRE
Tenaya Receives Orphan Drug Designation from the U.S. FDA for its Gene Therapy
28 Nov 2022 //
GLOBENEWSWIRE
Tenaya Therapeutics to Participate in Piper Sandler Healthcare Conference
23 Nov 2022 //
GLOBENEWSWIRE
Tenaya Therapeutics Announces Closing of Public Offering
21 Nov 2022 //
GLOBENEWSWIRE
Tenaya bags $75M from stock sale
17 Nov 2022 //
ENDPTS
Tenaya Therapeutics Announces Proposed Public Offering
16 Nov 2022 //
GLOBENEWSWIRE
Tenaya Therapeutics to Present Preclincial Study Data from TN-301
04 Nov 2022 //
GLOBENEWSWIRE
Tenaya to Present Preclinical Data on Its Novel Engineered AAV Capsids
04 Oct 2022 //
GLOBENEWSWIRE
Tenaya to Participate in Upcoming October Investor & Industry Conferences
29 Sep 2022 //
GLOBENEWSWIRE
Tenaya Therapeutics to Participate in Inaugural Hypertrophic Cardiomyopathy
29 Sep 2022 //
GLOBENEWSWIRE
Tenaya Therapeutics Announces FDA Clearance ofInvestigational NDA and Initiation
06 Sep 2022 //
GLOBENEWSWIRE
Tenaya Therapeutics to Participate in Upcoming September Investor Conferences
06 Sep 2022 //
GLOBENEWSWIRE
Tenaya Therapeutics Reports Q2 Financial Results and Provides Business Update
10 Aug 2022 //
GLOBENEWSWIRE
Tenaya tackles genetic heart disease after nailing down target
11 Jul 2022 //
FIERCEBIOTECH
Tenaya Tx Publishes PC Data in STM Detailing Discovery of HDAC6 Inhibitor
06 Jul 2022 //
GLOBENEWSWIRE
Tenaya Tx Launches Operations of New Genetic Medicines Manufacturing Center
16 Jun 2022 //
BUSINESSWIRE
Tenaya Therapeutics to Present Preclinical Data on TN-301 HDAC6 Inhibitor
20 May 2022 //
BUSINESSWIRE
Tenaya Therapeutics Reports Q1 2022 Financial Results
11 May 2022 //
BUSINESSWIRE
Tenaya Therapeutics To Present Preclinical Data On Gene Therapy Programs
03 May 2022 //
PRESS RELEASE
Tenaya to Present Preclinical Data on TN-401 PKP2 Gene Therapy Program
28 Apr 2022 //
BUSINESSWIRE
Tenaya Therapeutics to Participate in Upcoming Investor Conferences
24 Mar 2022 //
BUSINESSWIRE
Tenaya Tx Reports Q4 and Year-End 2021 Financial Results
23 Mar 2022 //
BUSINESSWIRE
Why Earnings Season Could Be Great for Tenaya Therapeutics (TNYA)
23 Feb 2022 //
NASDAQ
Tenaya Announces the Addition of Dr. June Lee to its Board of Directors
22 Nov 2021 //
BUSINESSWIRE
Tenaya to Present Preclinical Data on Its Gene Therapy Programs at ESGCT
12 Oct 2021 //
BUSINESSWIRE
Tenaya Therapeutics Reports Second Quarter 2021 Financial Results
08 Sep 2021 //
BUSINESSWIRE
Tenaya Therapeutics Unveils Preclinical Research Supporting Product Candidate
13 Jul 2021 //
BUSINESSWIRE
Tenaya Therapeutics decides now is the time to IPO
12 Jul 2021 //
FIERCEBIOTECH
Gene Therapy Gets Orphan Drug Status for Genetic Hypertrophic Cardiomyopathy
20 May 2021 //
BUSINESSWIRE
Tenaya grabs $106M top-up to push heart disease gene therapies
01 Mar 2021 //
FIERCEBIOTECH
